Skip to main content
Erschienen in: Endocrine Pathology 4/2009

01.12.2009

Loss of Cytochrome P450 17A1 Protein Expression in a 17α-Hydroxylase/17,20-Lyase-Deficient 46,XY Female Caused by Two Novel Mutations in the CYP17A1 Gene

verfasst von: Nayelli Nájera, Nayely Garibay, Yadira Pastrana, Icela Palma, Yolanda-Rocio Peña, Javier Pérez, Ninel Coyote, Alberto Hidalgo, Susana Kofman-Alfaro, Gloria Queipo

Erschienen in: Endocrine Pathology | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

17α-Hydroxylase deficiency (17OHD) is a rare form of congenital adrenal hyperplasia caused by mutations in the CYP17A1 gene. This condition shows considerable clinical and biochemical variation. Molecular characterization of novel mutations in the CYP17A1 gene and detailed study of their structural, enzymatic, and clinical consequences are required to fully understand enzyme behavior. Here, we present the first molecular characterization of two novel mutations in CYP17A1 in a 15-year-old female Mexican mestizo 46,XY female with primary amenorrhea and lack of pubertal development and severe hypertension that manifested only after surgery. A complete clinical and biochemical evaluation was compatible with 17OHD. Structural anomalies in the CYP17A1 gene were discovered by direct automated sequencing, which revealed a novel compound heterozygous K110X/R362H mutation that leads to a complete lack of enzyme activity. Immunohistochemical analyses performed to determine protein expression and localization showed that cytochrome P450 17A1 was completely absent in the patient’s testicular tissue. Studies of novel mutations, such as those described here, provide important information that allows us to better understand the effect of a given mutation on enzyme function and to observe the impact of the mutation on clinical phenotype.
Literatur
1.
Zurück zum Zitat Van Den Akker EL, Koper JW, Boehmer AL, Themmen AP, Verhoef-Post M, Timmerman MA, et al. Differential Inhibition of 17b-Hydroxylase and 17,20-Lyase Activities by three novel missense CYP17 mutations Identified in patients with P450c17 deficiency. J Clin Endocrinol Metab 87:5714–5721, 2002.CrossRef Van Den Akker EL, Koper JW, Boehmer AL, Themmen AP, Verhoef-Post M, Timmerman MA, et al. Differential Inhibition of 17b-Hydroxylase and 17,20-Lyase Activities by three novel missense CYP17 mutations Identified in patients with P450c17 deficiency. J Clin Endocrinol Metab 87:5714–5721, 2002.CrossRef
2.
Zurück zum Zitat New MI. Male pseudohermaphroditism due to 17alpha-hydroxylase deficiency. J Clin Invest 49:1930–1941, 1970.CrossRefPubMed New MI. Male pseudohermaphroditism due to 17alpha-hydroxylase deficiency. J Clin Invest 49:1930–1941, 1970.CrossRefPubMed
3.
Zurück zum Zitat Auchus RJ. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North America 30:101–119, 2001.CrossRef Auchus RJ. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North America 30:101–119, 2001.CrossRef
4.
Zurück zum Zitat Di Cerbo A, Biason-Lauber A, Savino M, Piemontese MR, Di Giorgio A, Perona M, et al. Combined 17alpha-hydroxylase/17,20-lyase deficiency caused by Phe93Cys mutation in the CYP17 gene. J Clin Endocrinol Metab 87:898–905, 2002.CrossRefPubMed Di Cerbo A, Biason-Lauber A, Savino M, Piemontese MR, Di Giorgio A, Perona M, et al. Combined 17alpha-hydroxylase/17,20-lyase deficiency caused by Phe93Cys mutation in the CYP17 gene. J Clin Endocrinol Metab 87:898–905, 2002.CrossRefPubMed
5.
Zurück zum Zitat Katsumata N, Satoh M, Mikami A, Mikami S, Nagashima-Miyokawa A, Sato N, et al. New compound heterozygous mutation in the CYP17 gene in a 46, XY girl with 17alpha-hydroxylase/17,20-lyase deficiency. Horm Res 55:141–146, 2001.CrossRefPubMed Katsumata N, Satoh M, Mikami A, Mikami S, Nagashima-Miyokawa A, Sato N, et al. New compound heterozygous mutation in the CYP17 gene in a 46, XY girl with 17alpha-hydroxylase/17,20-lyase deficiency. Horm Res 55:141–146, 2001.CrossRefPubMed
6.
Zurück zum Zitat Lam CW, Arlt W, Chan CK, Honour JW, Lin CJ, Tong SF, et al. Mutation of proline 409 to arginine in the meander region of cytochrome p450c17 causes severe 17alpha-hydroxylase deficiency. Mol Genet Metab 72:254–259, 2001.CrossRefPubMed Lam CW, Arlt W, Chan CK, Honour JW, Lin CJ, Tong SF, et al. Mutation of proline 409 to arginine in the meander region of cytochrome p450c17 causes severe 17alpha-hydroxylase deficiency. Mol Genet Metab 72:254–259, 2001.CrossRefPubMed
7.
Zurück zum Zitat Takeda Y, Yoneda T, Demura M, Furukawa K, Koshida H, Miyamori I, et al. Genetic analysis of the cytochrome P-450c17alpha (CYP17) and aldosterone synthase (CYP11B2) in Japanese patients with 17alpha-hydroxylase deficiency. Clin Endocrinol (Oxf) 54:751–758, 2001.CrossRef Takeda Y, Yoneda T, Demura M, Furukawa K, Koshida H, Miyamori I, et al. Genetic analysis of the cytochrome P-450c17alpha (CYP17) and aldosterone synthase (CYP11B2) in Japanese patients with 17alpha-hydroxylase deficiency. Clin Endocrinol (Oxf) 54:751–758, 2001.CrossRef
8.
Zurück zum Zitat Geller DH, Auchus RJ, Mendonça BB, Miller WL. The genetic and functional basis of isolated 17,20-lyase deficiency. Nat Genet 17:201–205, 1997.CrossRefPubMed Geller DH, Auchus RJ, Mendonça BB, Miller WL. The genetic and functional basis of isolated 17,20-lyase deficiency. Nat Genet 17:201–205, 1997.CrossRefPubMed
9.
Zurück zum Zitat Yanase T, Simpson ER, Waterman MR. 17alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12:91–108, 1991.CrossRefPubMed Yanase T, Simpson ER, Waterman MR. 17alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12:91–108, 1991.CrossRefPubMed
10.
Zurück zum Zitat Costa-Santos M, Kater CE, Auchus RJ. Brazilian Congenital Adrenal Hyperplasia Multicenter Study Group Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hidroxylase deficiency. J Clin Endocrinol Metab 89:49-60, 2004.CrossRefPubMed Costa-Santos M, Kater CE, Auchus RJ. Brazilian Congenital Adrenal Hyperplasia Multicenter Study Group Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hidroxylase deficiency. J Clin Endocrinol Metab 89:49-60, 2004.CrossRefPubMed
11.
Zurück zum Zitat Won GS, Chiu CY, Tso YC, Jenq SF, Cheng PS, Jap TS. A compound heterozygous mutation in the CYP17 (17alpha-hydroxylase/17,20- lyase) gene in a Chinese subject with congenital adrenal hyperplasia. Metabolism 56:504-507, 2007.CrossRefPubMed Won GS, Chiu CY, Tso YC, Jenq SF, Cheng PS, Jap TS. A compound heterozygous mutation in the CYP17 (17alpha-hydroxylase/17,20- lyase) gene in a Chinese subject with congenital adrenal hyperplasia. Metabolism 56:504-507, 2007.CrossRefPubMed
12.
Zurück zum Zitat Martin RM, Lin CJ, Costa EM, de Oliveira ML, Carrilho A, Villar H, Longui CA, Mendonca BB. P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping. J Clin Endocrinol Metab 88:5739-5746, 2003.CrossRefPubMed Martin RM, Lin CJ, Costa EM, de Oliveira ML, Carrilho A, Villar H, Longui CA, Mendonca BB. P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping. J Clin Endocrinol Metab 88:5739-5746, 2003.CrossRefPubMed
13.
Zurück zum Zitat Yang J, Cui B, Sun S, Shi T, Zheng S, Bi Y, et al. Phenotype-genotype correlation in eight Chinese 17alpha-hydroxylase/17,20 lyase-deficiency patients with five novel mutations of CYP17A1 gene. J Clin Endocrinol Metab 91:3619-3625, 2006.CrossRefPubMed Yang J, Cui B, Sun S, Shi T, Zheng S, Bi Y, et al. Phenotype-genotype correlation in eight Chinese 17alpha-hydroxylase/17,20 lyase-deficiency patients with five novel mutations of CYP17A1 gene. J Clin Endocrinol Metab 91:3619-3625, 2006.CrossRefPubMed
14.
Zurück zum Zitat Müssig K, Kaltenbach S, Machicao F, Maser-Gluth C, Hartmann MF, Wudy SA, et al. 17α-Hydroxylase/17,20-lyase deficiency caused by a novel homozygous mutation (Y27Stop) in the cytochrome CYP17 Gene. J Clin Endocrinol Metab 90:4362-4365, 2005.CrossRefPubMed Müssig K, Kaltenbach S, Machicao F, Maser-Gluth C, Hartmann MF, Wudy SA, et al. 17α-Hydroxylase/17,20-lyase deficiency caused by a novel homozygous mutation (Y27Stop) in the cytochrome CYP17 Gene. J Clin Endocrinol Metab 90:4362-4365, 2005.CrossRefPubMed
15.
Zurück zum Zitat Miura K, Yasuda K, Yanase T, Yamakita N, Sasano H, Nawata H, et al. Mutations of cytochrome P-45017 alpha gene (CYP17) in Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism with a review of Japanese patients with mutations of CYP17. J Clin Endocrinol Metab 81: 3797-3801, 1996.CrossRefPubMed Miura K, Yasuda K, Yanase T, Yamakita N, Sasano H, Nawata H, et al. Mutations of cytochrome P-45017 alpha gene (CYP17) in Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism with a review of Japanese patients with mutations of CYP17. J Clin Endocrinol Metab 81: 3797-3801, 1996.CrossRefPubMed
16.
Zurück zum Zitat Wei JQ, Wei JL, Li WC, Bi YS, Wei FC. Genotyping of five Chinese patients with 17α-hydroxylase deficiency diagnosed through high performance liquid chromatography serum adrenal profile: Identification of two novel CYP17 mutations. J Clin Endocrinol Metab 91:3647-3653, 2006.CrossRefPubMed Wei JQ, Wei JL, Li WC, Bi YS, Wei FC. Genotyping of five Chinese patients with 17α-hydroxylase deficiency diagnosed through high performance liquid chromatography serum adrenal profile: Identification of two novel CYP17 mutations. J Clin Endocrinol Metab 91:3647-3653, 2006.CrossRefPubMed
17.
Zurück zum Zitat Bhangoo A, Aisenberg J, Chartoffe A, Ten S, Wallerstein RJ, Wolf R, Auchus RJ. Novel mutation in cytochrome P450c17 causes complete combined 17alpha-hydroxylase/17,20-lyase deficiency. J Pediatr Endocrinol Metab 21:185-190, 2008.PubMed Bhangoo A, Aisenberg J, Chartoffe A, Ten S, Wallerstein RJ, Wolf R, Auchus RJ. Novel mutation in cytochrome P450c17 causes complete combined 17alpha-hydroxylase/17,20-lyase deficiency. J Pediatr Endocrinol Metab 21:185-190, 2008.PubMed
18.
Zurück zum Zitat Riepe F, Tatzel S, Sippell WG, Pleiss J, Krone N. Congenital adrenal hyperplasia: the molecular basis of 21-hydroxylase deficiency in H-2(aw18) mice. Endocrinology 146:2563-2574, 2006.CrossRef Riepe F, Tatzel S, Sippell WG, Pleiss J, Krone N. Congenital adrenal hyperplasia: the molecular basis of 21-hydroxylase deficiency in H-2(aw18) mice. Endocrinology 146:2563-2574, 2006.CrossRef
19.
Zurück zum Zitat Auchus RJ, Miller WL. Molecular modeling of human P450c17 (17 alphahidroxylase/17,20-lyase: insights into reaction mechanisms and effects of mutations. Mol Endocrinol 13:1169–1182, 1999.CrossRefPubMed Auchus RJ, Miller WL. Molecular modeling of human P450c17 (17 alphahidroxylase/17,20-lyase: insights into reaction mechanisms and effects of mutations. Mol Endocrinol 13:1169–1182, 1999.CrossRefPubMed
20.
Zurück zum Zitat Fardella CE, Zhang LH, Mahachoklertwattana P, Lin D, Miller WL. Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450c17 causes severe 17alpha-hydroxylase deficiency. J Clin Endocrinol Metab 77:489–493, 1993.CrossRefPubMed Fardella CE, Zhang LH, Mahachoklertwattana P, Lin D, Miller WL. Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450c17 causes severe 17alpha-hydroxylase deficiency. J Clin Endocrinol Metab 77:489–493, 1993.CrossRefPubMed
21.
Zurück zum Zitat Imai T, Yanase T, Waterman MR, Simpson ER, Pratt JJ. Canadian Mennonites and individuals residing in the Friesland region of The Netherlands share the same molecular basis of 17 alpha-hydroxylase deficiency. Hum Genet 89: 95-96, 1992.CrossRefPubMed Imai T, Yanase T, Waterman MR, Simpson ER, Pratt JJ. Canadian Mennonites and individuals residing in the Friesland region of The Netherlands share the same molecular basis of 17 alpha-hydroxylase deficiency. Hum Genet 89: 95-96, 1992.CrossRefPubMed
22.
Zurück zum Zitat Chen Y, Belleamy WP, Seabra MC, Field MC, Bassam EA. ER-associated protein degradation is a common mechanisms underpinning numerous monogenic disease including Robinow syndrome. Hum Mol Genet 14:2559-2569, 2005.CrossRefPubMed Chen Y, Belleamy WP, Seabra MC, Field MC, Bassam EA. ER-associated protein degradation is a common mechanisms underpinning numerous monogenic disease including Robinow syndrome. Hum Mol Genet 14:2559-2569, 2005.CrossRefPubMed
23.
Zurück zum Zitat Ishii S, Chang H, Kawasaki K, Yusuda K, Wu H, Garman S, Fan JQ. Mutant α-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimcycin. J Biochem (Tokyo) 406:285-295, 2007. Ishii S, Chang H, Kawasaki K, Yusuda K, Wu H, Garman S, Fan JQ. Mutant α-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimcycin. J Biochem (Tokyo) 406:285-295, 2007.
24.
Zurück zum Zitat Gallagher M, Ding L, Maheshwari A, Macdonald R. The GABAa receptor α1 subunit epilepsy mutation A322D inhibits transmembrane helix formation and causes proteosomal degradation. Proc Natl Acad Sci USA 104:12999-13004, 2007.CrossRefPubMed Gallagher M, Ding L, Maheshwari A, Macdonald R. The GABAa receptor α1 subunit epilepsy mutation A322D inhibits transmembrane helix formation and causes proteosomal degradation. Proc Natl Acad Sci USA 104:12999-13004, 2007.CrossRefPubMed
Metadaten
Titel
Loss of Cytochrome P450 17A1 Protein Expression in a 17α-Hydroxylase/17,20-Lyase-Deficient 46,XY Female Caused by Two Novel Mutations in the CYP17A1 Gene
verfasst von
Nayelli Nájera
Nayely Garibay
Yadira Pastrana
Icela Palma
Yolanda-Rocio Peña
Javier Pérez
Ninel Coyote
Alberto Hidalgo
Susana Kofman-Alfaro
Gloria Queipo
Publikationsdatum
01.12.2009
Verlag
Humana Press Inc
Erschienen in
Endocrine Pathology / Ausgabe 4/2009
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-009-9088-9

Weitere Artikel der Ausgabe 4/2009

Endocrine Pathology 4/2009 Zur Ausgabe

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …